{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:41:56Z","timestamp":1793234516885,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s11060-026-05802-1","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T16:00:21Z","timestamp":1789574421000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of 5-ALA and sodium fluorescein on FLAIR volume extent of resection and survival in IDH-wildtype glioblastoma"],"prefix":"10.1007","volume":"179","author":[{"given":"Castaldo","family":"Margherita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeppa","family":"Pietro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1014-0731","authenticated-orcid":false,"given":"Bianconi","family":"Andrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradaschia","family":"Leonardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolci","family":"Lorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Francesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Melcarne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morana","family":"Giovanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rud\u00e0","family":"Roberta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garbossa","family":"Diego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cofano","family":"Fabio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"5802_CR1","doi-asserted-by":"publisher","first-page":"iii1","DOI":"10.1093\/neuonc\/noab200","volume":"23","author":"QT Ostrom","year":"2021","unstructured":"Ostrom QT, Cioffi G, Waite K et al (2021) CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014\u20132018. Neuro Oncol 23:iii1\u2013iii105. https:\/\/doi.org\/10.1093\/neuonc\/noab200","journal-title":"Neuro Oncol"},{"key":"5802_CR2","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P et al (2021) The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol 23:1231\u20131251. https:\/\/doi.org\/10.1093\/neuonc\/noab106","journal-title":"Neuro Oncol"},{"key":"5802_CR3","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, van den Mason WP et al (2005) Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma. N Engl J Med 352:987\u2013996. https:\/\/doi.org\/10.1056\/NEJMoa043330","journal-title":"N Engl J Med"},{"key":"5802_CR4","doi-asserted-by":"publisher","unstructured":"Bruno F, Pellerino A, Pronello E et al (2022) Elderly gliobastoma patients: the impact of surgery and adjuvant treatments on survival: a single institution experience. Brain Sci 12. https:\/\/doi.org\/10.3390\/BRAINSCI12050632","DOI":"10.3390\/BRAINSCI12050632"},{"key":"5802_CR5","doi-asserted-by":"publisher","unstructured":"Bianconi A, Koumantakis E, Gatto A et al (2023) Effects of Levetiracetam and Lacosamide on survival and seizure control in IDH-wild type glioblastoma during temozolomide plus radiation adjuvant therapy. Brain spine 4. https:\/\/doi.org\/10.1016\/J.BAS.2023.102732","DOI":"10.1016\/J.BAS.2023.102732"},{"key":"5802_CR6","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1093\/NEUONC\/NOAC193","volume":"25","author":"P Karschnia","year":"2022","unstructured":"Karschnia P, Young JS, Dono A et al (2022) Prognostic validation of a new classification system for extent of resection in glioblastoma: A report of the RANO resect group. Neuro Oncol 25:940. https:\/\/doi.org\/10.1093\/NEUONC\/NOAC193","journal-title":"Neuro Oncol"},{"key":"5802_CR7","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1227\/NEU.0000000000000929","volume":"77","author":"CG Hadjipanayis","year":"2015","unstructured":"Hadjipanayis CG, Widhalm G, Stummer W (2015) What is the surgical benefit of utilizing 5-aminolevulinic acid for fluorescence-guided surgery of malignant gliomas? Neurosurgery 77:663\u2013673. https:\/\/doi.org\/10.1227\/NEU.0000000000000929","journal-title":"Neurosurgery"},{"key":"5802_CR8","doi-asserted-by":"publisher","unstructured":"Pesaresi A, La Cava P, Bonada M et al (2024) Combined fluorescence-guided surgery with 5-aminolevulinic acid and fluorescein in glioblastoma: technical description and report of 100 cases. Cancers 16:2771. https:\/\/doi.org\/10.3390\/CANCERS16162771","DOI":"10.3390\/CANCERS16162771"},{"key":"5802_CR9","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1093\/NEUROS\/NYAA475","volume":"89","author":"C Orillac","year":"2021","unstructured":"Orillac C, Stummer W, Orringer DA (2021) Fluorescence Guidance and Intraoperative Adjuvants to Maximize Extent of Resection. Neurosurgery 89:727\u2013736. https:\/\/doi.org\/10.1093\/NEUROS\/NYAA475","journal-title":"Neurosurgery"},{"key":"5802_CR10","doi-asserted-by":"publisher","unstructured":"Bianconi A, Bonada M, Zeppa P et al (2025) Double fluorescence-guided surgery with 5-ALA and fluorescein sodium in grade 2 and grade 3 adult-type diffuse gliomas: retrospective analysis of 112 cases. Brain spine 5. https:\/\/doi.org\/10.1016\/J.BAS.2025.104277","DOI":"10.1016\/J.BAS.2025.104277"},{"key":"5802_CR11","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1158\/1078-0432.CCR-17-1184\/116621","volume":"24","author":"F Acerbi","year":"2018","unstructured":"Acerbi F, Broggi M, Schebesch KM et al (2018) Fluorescein-guided surgery for resection of high-grade gliomas: A multicentric prospective phase II study (FLUOGLIO). Clin Cancer Res 24:52\u201361. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-1184\/116621\/AM\/FLUORESCEIN-GUIDED-SURGERY-FOR-RESECTION-OF-HIGH.","journal-title":"Clin Cancer Res"},{"key":"5802_CR12","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/S1470-2045(06)70665-9","volume":"7","author":"W Stummer","year":"2006","unstructured":"Stummer W, Pichlmeier U, Meinel T et al (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7:392\u2013401. https:\/\/doi.org\/10.1016\/S1470-2045(06)70665-9","journal-title":"Lancet Oncol"},{"key":"5802_CR13","doi-asserted-by":"publisher","unstructured":"Zeppa P, De Marco R, Monticelli M et al (2022) Fluorescence-guided surgery in glioblastoma: 5-ALA, SF or both? Differences between Fluorescent Dyes in 99 Consecutive Cases. Brain Sci 12. https:\/\/doi.org\/10.3390\/BRAINSCI12050555","DOI":"10.3390\/BRAINSCI12050555"},{"key":"5802_CR14","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1093\/NEUROS\/NYX074","volume":"81","author":"W Stummer","year":"2017","unstructured":"Stummer W, Stepp H, Wiestler OD, Pichlmeier U (2017) Randomized, Prospective Double-Blinded Study Comparing 3 Different Doses of 5-Aminolevulinic Acid for Fluorescence-Guided Resections of Malignant Gliomas. Neurosurgery 81:230\u2013239. https:\/\/doi.org\/10.1093\/NEUROS\/NYX074","journal-title":"Neurosurgery"},{"key":"5802_CR15","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/J.NEUROL.2011.07.004","volume":"167","author":"N Sanai","year":"2011","unstructured":"Sanai N, Berger MS (2011) Extent of resection influences outcomes for patients with gliomas. Rev Neurol (Paris) 167:648\u2013654. https:\/\/doi.org\/10.1016\/J.NEUROL.2011.07.004","journal-title":"Rev Neurol (Paris)"},{"key":"5802_CR16","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3171\/jns.2001.95.2.0190","volume":"95","author":"M Lacroix","year":"2001","unstructured":"Lacroix M, Abi-Said D, Fourney DR et al (2001) A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95:190\u2013198. https:\/\/doi.org\/10.3171\/jns.2001.95.2.0190","journal-title":"J Neurosurg"},{"key":"5802_CR17","doi-asserted-by":"publisher","first-page":"977","DOI":"10.3171\/2015.5.JNS142087","volume":"124","author":"YM Li","year":"2016","unstructured":"Li YM, Suki D, Hess K, Sawaya R (2016) The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection? J Neurosurg 124:977\u2013988. https:\/\/doi.org\/10.3171\/2015.5.JNS142087","journal-title":"J Neurosurg"},{"key":"5802_CR18","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s11060-017-2559-9","volume":"135","author":"F Pessina","year":"2017","unstructured":"Pessina F, Navarria P, Cozzi L et al (2017) Maximize surgical resection beyond contrast-enhancing boundaries in newly diagnosed glioblastoma multiforme: is it useful and safe? A single institution retrospective experience. J Neurooncol 135:129\u2013139. https:\/\/doi.org\/10.1007\/s11060-017-2559-9","journal-title":"J Neurooncol"},{"key":"5802_CR19","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/ONS\/OPAA293","volume":"20","author":"F Certo","year":"2021","unstructured":"Certo F, Altieri R, Maione M et al (2021) FLAIRectomy in Supramarginal Resection of Glioblastoma Correlates With Clinical Outcome and Survival Analysis: A Prospective, Single Institution, Case Series. Oper Neurosurg (Hagerstown) 20:151\u2013163. https:\/\/doi.org\/10.1093\/ONS\/OPAA293","journal-title":"Oper Neurosurg (Hagerstown)"},{"key":"5802_CR20","doi-asserted-by":"publisher","first-page":"5187","DOI":"10.1200\/JCO.23.01059\/SUPPL_FILE\/DS_JCO.23.01059.PDF","volume":"41","author":"PY Van Den Wen","year":"2023","unstructured":"Van Den Wen PY, Youssef G et al (2023) RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults. J Clin Oncol 41:5187\u20135199. https:\/\/doi.org\/10.1200\/JCO.23.01059\/SUPPL_FILE\/DS_JCO.23.01059.PDF","journal-title":"J Clin Oncol"},{"key":"5802_CR21","doi-asserted-by":"publisher","unstructured":"Cepeda S, Romero R, Luque L et al (2024) Deep learning-based postoperative glioblastoma segmentation and extent of resection evaluation: Development, external validation, and model comparison. Neurooncol Adv 6. https:\/\/doi.org\/10.1093\/NOAJNL\/VDAE199","DOI":"10.1093\/NOAJNL\/VDAE199"},{"key":"5802_CR22","doi-asserted-by":"publisher","first-page":"544","DOI":"10.3390\/BRAINSCI12050544","volume":"12","author":"AF Haddad","year":"2022","unstructured":"Haddad AF, Young JS, Morshed RA, Berger MS (2022) FLAIRectomy: Resecting beyond the Contrast Margin for Glioblastoma. Brain Sci 12:544. https:\/\/doi.org\/10.3390\/BRAINSCI12050544","journal-title":"Brain Sci"},{"key":"5802_CR23","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/J.WNEU.2019.04.092","volume":"127","author":"F Incekara","year":"2019","unstructured":"Incekara F, Koene S, Vincent AJPE et al (2019) Association Between Supratotal Glioblastoma Resection and Patient Survival: A Systematic Review and Meta-Analysis. World Neurosurg 127:617\u2013624e2. https:\/\/doi.org\/10.1016\/J.WNEU.2019.04.092","journal-title":"World Neurosurg"},{"key":"5802_CR24","doi-asserted-by":"publisher","first-page":"e404","DOI":"10.1016\/S1470-2045(24)00130-X\/ASSET\/AEED396C-8FE2-4B4E-9A45-A332E2CC26F1\/MAIN.ASSETS\/GR2.JPG","volume":"25","author":"P Karschnia","year":"2024","unstructured":"Karschnia P, Gerritsen JKW, Teske N et al (2024) The oncological role of resection in newly diagnosed diffuse adult-type glioma defined by the WHO 2021 classification: a Review by the RANO resect group. Lancet Oncol 25:e404\u2013e419. https:\/\/doi.org\/10.1016\/S1470-2045(24)00130-X\/ASSET\/AEED396C-8FE2-4B4E-9A45-A332E2CC26F1\/MAIN.ASSETS\/GR2.JPG","journal-title":"Lancet Oncol"},{"key":"5802_CR25","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1001\/jamaoncol.2016.1373","volume":"2","author":"TJ Brown","year":"2016","unstructured":"Brown TJ, Brennan MC, Li M et al (2016) Association of the Extent of Resection With Survival in Glioblastoma: A Systematic Review and Meta-analysis. JAMA Oncol 2:1460\u20131469. https:\/\/doi.org\/10.1001\/jamaoncol.2016.1373","journal-title":"JAMA Oncol"},{"key":"5802_CR26","doi-asserted-by":"publisher","unstructured":"Goran A, Lasocki A, Dimou J (2025) Standardisation of the radiological definition of supramaximal resection in glioblastoma. J Clin Neurosci 133. https:\/\/doi.org\/10.1016\/J.JOCN.2025.111037","DOI":"10.1016\/J.JOCN.2025.111037"},{"key":"5802_CR27","doi-asserted-by":"publisher","unstructured":"Broggi G, Altieri R, Barresi V et al (2023) Histologic definition of enhancing core and FLAIR hyperintensity region of glioblastoma, IDH-wild type: a clinico-pathologic study on a single-institution series. Brain Sci 13. https:\/\/doi.org\/10.3390\/BRAINSCI13020248","DOI":"10.3390\/BRAINSCI13020248"},{"key":"5802_CR28","doi-asserted-by":"crossref","unstructured":"Altieri R, Barbagallo D, Certo F et al (2021) Peritumoral microenvironment in high-grade gliomas: From flairectomy to microglia\u2013glioma cross-talk. Brain Sci 11","DOI":"10.3390\/brainsci11020200"},{"key":"5802_CR29","doi-asserted-by":"publisher","DOI":"10.1093\/NOP\/NPAG065","author":"A Bianconi","year":"2026","unstructured":"Bianconi A, Pesaresi A, de Marco R et al (2026) [18F]DOPA PET identifies metabolically active tumor beyond contrast-enhancing margins in IDH-WT glioblastoma: A histopathology and fluorescence validation study. Neurooncol Pract. https:\/\/doi.org\/10.1093\/NOP\/NPAG065","journal-title":"Neurooncol Pract"},{"key":"5802_CR30","doi-asserted-by":"publisher","first-page":"3709","DOI":"10.1007\/S10143-022-01863-8","volume":"45","author":"R Altieri","year":"2022","unstructured":"Altieri R, Broggi G, Certo F et al (2022) Anatomical distribution of cancer stem cells between enhancing nodule and FLAIR hyperintensity in supratentorial glioblastoma: time to recalibrate the surgical target? Neurosurg Rev 45:3709\u20133716. https:\/\/doi.org\/10.1007\/S10143-022-01863-8","journal-title":"Neurosurg Rev"},{"key":"5802_CR31","doi-asserted-by":"publisher","unstructured":"Bianconi A, Bonada M, Zeppa P et al (2023) How reliable is fluorescence-guided surgery in low-grade gliomas? A systematic review concerning different fluorophores. Cancers (Basel) 15. https:\/\/doi.org\/10.3390\/CANCERS15164130","DOI":"10.3390\/CANCERS15164130"},{"key":"5802_CR32","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/S1470-2045(11)70196-6","volume":"12","author":"C Senft","year":"2011","unstructured":"Senft C, Bink A, Franz K et al (2011) Intraoperative MRI guidance and extent of resection in glioma surgery: a randomised, controlled trial. Lancet Oncol 12:997\u20131003. https:\/\/doi.org\/10.1016\/S1470-2045(11)70196-6","journal-title":"Lancet Oncol"},{"key":"5802_CR33","doi-asserted-by":"publisher","unstructured":"Trevisi G, Palermo M, Barbone P, Sturiale CL (2025) Illuminating glioma surgery: A meta-analysis of Raman spectroscopy for intraoperative decision-making. Neurosurg Rev 48. https:\/\/doi.org\/10.1007\/S10143-025-03836-Z","DOI":"10.1007\/S10143-025-03836-Z"},{"key":"5802_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-025-26245-0","volume":"15","author":"F D\u2019Alessandro","year":"2025","unstructured":"D\u2019Alessandro F, Walke A, Kiolbassa NM et al (2025) Integrating mass spectrometry and hyperspectral imaging for protoporphyrin IX detection in malignant glioma tissue. Sci Rep 2025 15:1. https:\/\/doi.org\/10.1038\/s41598-025-26245-0","journal-title":"Sci Rep 2025"},{"key":"5802_CR35","doi-asserted-by":"publisher","unstructured":"Walke A, Black D, Valdes PA et al (2023) Challenges in, and recommendations for, hyperspectral imaging in ex vivo malignant glioma biopsy measurements. Scientific Reports 13:3829. https:\/\/doi.org\/10.1038\/s41598-023-30680-2","DOI":"10.1038\/s41598-023-30680-2"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05802-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-026-05802-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05802-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:01:49Z","timestamp":1792087309000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-026-05802-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["5802"],"URL":"https:\/\/doi.org\/10.1007\/s11060-026-05802-1","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"21 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This retrospective study was performed in line with the principles of the Declaration of Helsinki. Based on the retrospective nature of the study and the use of previously collected, de-identified data, formal ethics committee approval was not required.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent to anonymized data treatment for scientific purposes was obtained from all individual participants included in the study.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"86"}}